Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_4
2
50%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Recruiting1
unknown1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)

Trials by Status

recruiting125%
unknown125%
withdrawn125%
completed125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Clinical Study Evaluating the Effect of Losartan

NCT06539806
unknownphase_2

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

NCT05871333
completedphase_4

Renohemodynamic Effects of Combined empagliflOzin and LosARtan

NCT04238702
withdrawnphase_4

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

NCT03978884

Clinical Trials (4)

Showing 4 of 4 trials
NCT06539806Not Applicable

Clinical Study Evaluating the Effect of Losartan

Recruiting
NCT05871333Phase 2

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Unknown
NCT04238702Phase 4

Renohemodynamic Effects of Combined empagliflOzin and LosARtan

Completed
NCT03978884Phase 4

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4